Mark Nagel

1.7k total citations
66 papers, 1.3k citations indexed

About

Mark Nagel is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Electrical and Electronic Engineering. According to data from OpenAlex, Mark Nagel has authored 66 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Pulmonary and Respiratory Medicine, 10 papers in Physiology and 9 papers in Electrical and Electronic Engineering. Recurrent topics in Mark Nagel's work include Inhalation and Respiratory Drug Delivery (47 papers), Asthma and respiratory diseases (10 papers) and Aerosol Filtration and Electrostatic Precipitation (7 papers). Mark Nagel is often cited by papers focused on Inhalation and Respiratory Drug Delivery (47 papers), Asthma and respiratory diseases (10 papers) and Aerosol Filtration and Electrostatic Precipitation (7 papers). Mark Nagel collaborates with scholars based in United States, United Kingdom and Canada. Mark Nagel's co-authors include Jolyon P. Mitchell, Hans‐Peter Gerber, Joe Kowalski, M. Teresa Pisabarro, Ming-Hong Xie, Daniel Sherman, Xiao Liang, Kevin Clark, Austin Gurney and Gieri Camenisch and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Mark Nagel

51 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Nagel United States 18 836 194 176 176 171 66 1.3k
Max R. Hardeman Netherlands 15 774 0.9× 623 3.2× 140 0.8× 18 0.1× 175 1.0× 28 1.5k
Erik N. Sorensen United States 16 218 0.3× 29 0.1× 197 1.1× 45 0.3× 441 2.6× 53 1.3k
Robert Sussman United States 12 2.9k 3.4× 780 4.0× 53 0.3× 125 0.7× 61 0.4× 20 3.3k
Vladimír Staněk Czechia 11 587 0.7× 72 0.4× 870 4.9× 21 0.1× 70 0.4× 51 1.7k
M Bachofen Switzerland 11 1.4k 1.6× 128 0.7× 52 0.3× 16 0.1× 169 1.0× 16 2.1k
Péter Fritz Germany 21 239 0.3× 77 0.4× 663 3.8× 33 0.2× 43 0.3× 82 1.9k
Howard S. Oster Israel 16 70 0.1× 78 0.4× 324 1.8× 99 0.6× 64 0.4× 55 925
Klaus Gottlieb United States 31 1.5k 1.8× 58 0.3× 35 0.2× 40 0.2× 121 0.7× 111 3.3k
Jeffrey J. Bishop United States 13 417 0.5× 261 1.3× 128 0.7× 8 0.0× 118 0.7× 19 681
John P. Mitchell United States 17 358 0.4× 39 0.2× 93 0.5× 15 0.1× 155 0.9× 41 2.0k

Countries citing papers authored by Mark Nagel

Since Specialization
Citations

This map shows the geographic impact of Mark Nagel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Nagel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Nagel more than expected).

Fields of papers citing papers by Mark Nagel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Nagel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Nagel. The network helps show where Mark Nagel may publish in the future.

Co-authorship network of co-authors of Mark Nagel

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Nagel. A scholar is included among the top collaborators of Mark Nagel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Nagel. Mark Nagel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Coates, Allan L., et al.. (2024). Are the Reference Values for the Provocative Concentration of Methacholine Appropriate for Children?. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 37(5). 220–224.
3.
Nagel, Mark. (2024). Student pharmacists lead the charge at 2024 APhA–ASP HoD. Journal of the American Pharmacists Association. 64(5). 102206–102206.
4.
Anderson, Sean M., Brian H. Lee, Andy Vail, et al.. (2023). Fiber chromatographic enabled process intensification increases monoclonal antibody product yield. Biotechnology and Bioengineering. 121(2). 757–770. 2 indexed citations
5.
Southall, Richard M. & Mark Nagel. (2021). NIL “Reform” Fails to Address the NCAA’s Biggest Issue.
8.
Sharpe, Richard E., et al.. (2014). Inhaled medication delivery to infants via valved holding chamber with facemask: Not all VHCs perform the same. European Respiratory Journal. 44(Suppl 58). P3528–P3528. 1 indexed citations
9.
Mitchell, Jolyon P., et al.. (2013). Antistatic valved holding chambers do not necessarily offer similar aerosol delivery performance. European Respiratory Journal. 42(Suppl 57). P2407–P2407. 3 indexed citations
12.
Mitchell, Jolyon P. & Mark Nagel. (2009). Oral inhalation therapy: meeting the challenge of developing more patient-appropriate devices. Expert Review of Medical Devices. 6(2). 147–155. 7 indexed citations
13.
Myrdal, Paul B., et al.. (2006). Application of Heated Inlet Extensions to the TSI 3306/3321 System: Comparison with the Andersen Cascade Impactor and Next Generation Impactor. Journal of Aerosol Medicine. 19(4). 543–554. 4 indexed citations
14.
Louca, Emily, Kitty Leung, Allan L. Coates, Jolyon P. Mitchell, & Mark Nagel. (2006). Comparison of Three Valved Holding Chambers for the Delivery of Fluticasone Propionate–HFA to an Infant Face Model. Journal of Aerosol Medicine. 19(2). 160–167. 25 indexed citations
15.
Mitchell, Jolyon P., et al.. (2006). Laser Diffractometry as a Technique for the Rapid Assessment of Aerosol Particle Size from Inhalers. Journal of Aerosol Medicine. 19(4). 409–433. 84 indexed citations
17.
Mitchell, Jolyon P. & Mark Nagel. (2003). Cascade Impactors for the Size Characterization of Aerosols from Medical Inhalers: Their Uses and Limitations. Journal of Aerosol Medicine. 16(4). 341–377. 136 indexed citations
18.
Camenisch, Gieri, M. Teresa Pisabarro, Daniel Sherman, et al.. (2002). ANGPTL3 Stimulates Endothelial Cell Adhesion and Migration via Integrin αvβ3 and Induces Blood Vessel Formation in Vivo. Journal of Biological Chemistry. 277(19). 17281–17290. 205 indexed citations
19.
Mitchell, Jolyon P., Mark Nagel, & Joseph L. Rau. (1999). Performance of Large-Volume versus Small-Volume Holding Chambers with Chlorofluorocarbon-Albuterol and Hydrofluoroalkane-Albuterol Sulfate. Respiratory Care. 44(1). 38–44. 12 indexed citations
20.
Mitchell, Jolyon P., Mark Nagel, & Andrew J. Archer. (1999). Size Analysis of a Pressurized Metered Dose Inhaler–Delivered Suspension Formulation by the API Aerosizer Time-of-Flight Aerodynamic Particle Size Analyzer. Journal of Aerosol Medicine. 12(4). 255–264. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026